An optimal surveillance protocol for CRC includes CT scans, colonoscopies, and serum carcinoembryonic antigen (CEA) measurement, although this blood marker has a reduced sensitivity or specificity. This evidence concerns the gene CEACAM5 and colorectal carcinoma.